The paper's citation list
No.The paper's citation list
1Update on urine as a biomarker in cancer: a necessary review of an old story. 2020;20:477 doi: 10.1080/14737159.2020.1743687
2Liquid biopsy in chronic liver disease. 2020; doi: 10.1016/j.aohep.2020.03.008
3The value of cell-free DNA for molecular pathology. 2018;244:616 doi: 10.1002/path.5048
4Development and Evaluation of Novel Statistical Methods in Urine Biomarker-Based Hepatocellular Carcinoma Screening. 2018;8: doi: 10.1038/s41598-018-21922-9
5Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation. 2018;52:20 doi: 10.1016/j.clinbiochem.2017.10.011
6Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma. 2019;e693 doi: 10.1002/mgg3.693
7Liquid biopsies for hepatocellular carcinoma. 2018;201:84 doi: 10.1016/j.trsl.2018.07.001
8Urine-Based Liquid Biopsy for Nonurological Cancers. 2019;23:277 doi: 10.1089/gtmb.2018.0189
9Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook. 2018;5: doi: 10.3389/fmed.2018.00078
10The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. 2018;41:74 doi: 10.1016/j.coph.2018.04.002
11Liquid biopsy for liver diseases. 2018;67:2204 doi: 10.1136/gutjnl-2017-315846
12. 2019;89:131 doi: 10.1016/bs.acc.2018.12.004